CVSI logo

CV Sciences, Inc. Stock Price

OTCPK:CVSI Community·US$7.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CVSI Share Price Performance

US$0.037
-0.01 (-21.04%)
US$0.037
-0.01 (-21.04%)
Price US$0.037

CVSI Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet and slightly overvalued.

2 Risks
1 Reward

CV Sciences, Inc. Key Details

US$15.0m

Revenue

US$8.0m

Cost of Revenue

US$7.0m

Gross Profit

US$8.5m

Other Expenses

-US$1.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.0084
46.46%
-10.36%
68.3%
View Full Analysis

About CVSI

Founded
2010
Employees
48
CEO
Joseph Dowling
WebsiteView website
www.cvsciences.com

CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements, hemp-based cannabidiol (CBD), and plant based food products in North America. It offers its products under the PlusCBD, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.

Recent CVSI News & Updates

Recent updates

No updates